Wolfe Research Downgrades Kymera Therapeutics (KYMR) to Peerperform
Tweet Send to a Friend
(Updated - January 6, 2026 5:35 AM EST)
Wolfe Research analyst Andy Chen downgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wolfe Research analyst Andy Chen downgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
